Berkan Kurt: Inflammatory Biomarkers in Heart Failure
Berkan Kurt, Resident Physician in Cardiology and Internal Medicine at Uniklinik RWTH Aachen, reposted from Florian Kahles, on LinkedIn:
“In our new review, we look at heart failure with a focus on chronic low-grade inflammation, discuss how hsCRP, IL-6 and other biomarkers capture residual inflammatory risk in HFpEF and HFrEF and may help guide future anti-inflammatory strategies.
Also excited to share that this is the first publication of our MD student Konstantin Rex, who co-led the work. ”
Quoting Florian Kahles’s post:
“Happy to share our new review in Current Heart Failure Reports, “Inflammatory Biomarkers in Heart Failure: Clinical Perspectives on hsCRP, IL-6 and Emerging Candidates.”
We summarize how low-grade systemic inflammation drives HF pathobiology and outline the complementary roles of hsCRP as a practical risk marker and IL-6 as a causal pathway with therapeutic potential.
We also discuss implications for risk stratification, precision medicine, and ongoing IL-6–targeted trials in HF.”
Read the full article here.
Article: Inflammatory Biomarkers in Heart Failure: Clinical Perspectives on hsCRP, IL-6 and Emerging Candidates
Authors: Berkan Kurt, Konstantin Rex, Martin Reugels, Christopher B. Fordyce, Marat Fudim, Abhinav Sharma, Martin Berger, Nikolaus Marx, Katharina Marx-Schütt, Florian Kahles

Stay updated on all scientific advances with Hemostasis Today.
-
Jun 14, 2026, 22:49Cihan Ay: From First Oral Presentation to Pro and Con Debate – A 20-Year EHA Journey
-
Jun 14, 2026, 19:54Tareq Abadl: What Happens If You Transfuse the Wrong Blood Group?
-
Jun 14, 2026, 19:46Amber Yates: Stretching Scientific Muscles in Areas of Hematology – Day 2 at EHA 2026
-
Jun 14, 2026, 19:41Peter Loffelhardt: Thousands of People Coming in – Second Day at EHA 2026
-
Jun 14, 2026, 19:38Jecko Thachil: Can We Predict and Prevent Bleeding in APL?
-
Jun 14, 2026, 19:32Highlights from Day 1 at the EHC Leadership Conference 2026
-
Jun 14, 2026, 18:01Ahmar U. Zaidi: The First Pivotal Study of a New Mechanism in Sickle Cell Disease
-
Jun 14, 2026, 18:00Lennart Lenk: Witnessing Former Boss Deliver a Plenary Talk at EHA 2026
-
Jun 14, 2026, 18:00Priya Sriskandarajah: Great Presentations on Recent Advances in Myelofibrosis at EHA 2026